Full Description
Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population.
Contents
1. A global overview of the current state of deprescribing 2. Health policies and deprescribing: An introduction to health policies, knowledge translation, and the barriers, challenges, and enablers to health policy implementation 3. Deprescribing is an essential part of prescribing 4. Deprescribing in school curriculums: An overview of current education standards and what should be changed 5. The role of the multidisciplinary healthcare team in deprescribing 6. Looking to the future: Artificial intelligence in enhancing patient care 7. Challenges/barriers of deprescribing during Covid-19 8. Deprescribing in pallative care and Alzheimer's patients: Optimizing medication use for improved quality of life
